Projects per year
Personal profile
Education
- 2012 Ph.D. ISF College of Pharmacy, Punjab, India
- 2008 M.S. ISF College of Pharmacy, Punjab, India
- 2006 B.S. Rajiv Academy For Pharmacy. U.P,, India
Experience
- 2024.09 - Associate Editor, Journal of Enzyme Inhibition and Medicinal Chemistry (Taylor and Francis, Impact Factor - 5.6)
- 2023- Associate Professor, Department of Pharmaceutical Sciences, Taipei Medical UniversityTaipei Medical University
- 2019-2023 Assistant Professor, Department of Pharmaceutical Sciences, Taipei Medical University
- 2014-2019 Post-Doctoral Research Fellow, Taipei Medical University
- 2011-2014 Assistant Professor, Guru Nanak Dev University
- 2008-2011 Assistant Professor, Punjab Technical University
Awards
- Editorial Board Member, Medicinal Research Reviews (Wiley, Impact Factor - 10.9).
- Editorial board member - Mini Reviews in Medicinal chemistry (IF - 2.91, Chemistry/Medicinal)
- Plum Blossom Card (Permanent Resident Certificate) by Government of Taiwan 2020
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2018, Taipei Medical University, Taiwan.
Project title: The use of organometallic reaction in the synthesis of anticancer agents (2/2)
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2017, Taipei Medical University, Taiwan.
Project title: The use of organometallic reaction in the synthesis of anticancer agents
- Outstanding contribution in reviewing EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017.
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2016, Taipei Medical University, Taiwan.
Project title: Application of regioselective substitution on 1,4- Benzoquinone derivatives to provide potent anticancer agents
- Outstanding contribution in reviewing BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, 2016.
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2015, Taipei Medical University, Taiwan.
Project title: Preclinical development for novel HSP90 inhibitors as anticancer drugs
- Outstanding Post Doctoral Fellow (Medicinal Chemistry), 2015, Taipei Medical University, Taiwan
Project title: Development of ITCHE3 ubiquitin ligase inhibitors as anticancer drug
Research Interests
- Natural product chemistry
- Organic synthesis
- Medicinal chemistry
- Drug design
Fingerprint
Dive into the research topics where Kunal Nepali is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Click Chemistry and Suzuki Coupling Approach for the Construction of Small Molecule Bifunctional Inhibitors Targeting the Dna Damage Repair Pathways.
Nepali, K. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Click Chemistry and Suzuki Coupling Approach for the Construction of Small Molecule Bifunctional Inhibitors Targeting the Dna Damage Repair Pathways.
Nepali, K. (PI)
8/1/24 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
Click Chemistry and Suzuki Coupling Approach for the Construction of Small Molecule Bifunctional Inhibitors Targeting the Dna Damage Repair Pathways.
Nepali, K. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Rational Design of First-In-Class Dual Parp-Syk Inhibitors as Antitumor Agents
Nepali, K. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Development of a retinoic-base histone deacetylase inhibitor as early-stage AMD treatment
Nepali, K. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Efficient and Scalable Synthesis of Imidazo[1,2-a]pyridine-8-Carboxamides: a Versatile Methodology
Shah, D., Bhimani, B., Dabhi, R., Trivedi, V., Bhatia, R., Patel, D., Nepali, K. & Patel, A., Apr 2026, In: Journal of Pharmaceutical Innovation. 21, 2, 127.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus) -
In Silico Studies of Sembukan (Paederia scandens) Secondary Metabolites as Anti Diabetes Against Multiple Target Protein
Claus, M. P., Ariantika, L., Santoso, F., Aryati, W. D., Nepali, K. & Eden, W. T., Mar 2026, In: Walailak Journal of Science and Technology. 23, 3, 12090.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Multi-Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns
Thakur, A., Rana, M., Vanjani, S., Liou, K. C., Taliyan, R., Nepali, K. & Yang, C. H., 2026, In: Medicinal Research Reviews. 46, 4, p. 1173-1229 57 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics
Sharma, R., Rana, M., Thakur, A., Ojha, R., Mousavi, S. M., Dhingra, A. & Nepali, K., 2026, In: Journal of Enzyme Inhibition and Medicinal Chemistry. 41, 1, 2621477.Research output: Contribution to journal › Review article › peer-review
Open Access -
Recent advances in small molecule ATR kinase inhibitors as anticancer agents
Singh, G., Sharma, R., Gautam, V., Dhingra, A. K., Hsu, S. P. & Nepali, K., 2026, In: Future Medicinal Chemistry. 18, 6, p. 693-711 19 p.Research output: Contribution to journal › Review article › peer-review
Datasets
-
Design, synthesis and evaluation of 2,4-diarylpyrano[3,2-c]chromen-5(4H)-one as a new class of non-purine xanthine oxidase inhibitors
Virdi, H. S. (Creator), Sharma, S. (Contributor), Mehndiratta, S. (Creator), Bedi, P. M. S. (Contributor) & Nepali, K. (Contributor), Figshare, 2015
DOI: 10.6084/m9.figshare.1568378.v1, https://figshare.com/articles/Design_synthesis_and_evaluation_of_2_4_diarylpyrano_3_2_c_chromen_5_4H_one_as_a_new_class_of_non_purine_xanthine_oxidase_inhibitors/1568378/1
Dataset